Company: PMVP
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030414
Chunk: 247

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 8
Chunk 247
---

        $
        80,132

        $
        77,040

14. Subsequent EventsThe State of New Jersey’s Technology Business Tax Certificate Program allows certain high technology and biotechnology companies to sell NOL carryforwards and R&D tax credits to other New Jersey-based corporate taxpayers. The Company has applied for and received preliminary confirmation for its sale of NOLs related to the tax years ended December 31, 2021 to 2023 in the amount of approximately $2,196, which the Company expects to recognize in the second quarter of 2025, upon receipt of the certificates for the refund. Subsequent to December 31, 2024, the Company received $1,415 of cash for the NOL tax credit sales.

 124